Literature DB >> 15485527

Immunohistochemical study of serotonin in lesions of chronic eczema.

Jianguo Huang1, Guiming Li, Jihu Xiang, Daochun Yin, Ridong Chi.   

Abstract

BACKGROUND: Inflammatory mediators participate in the pathogenesis and pathophysiology of skin disease (e.g. eczema). Although some investigators have suggested that serotonin may participate in the eczematous process, there has been little substantial evidence. Our objective was to study further the participation of serotonin in the pathogenesis of chronic eczema.
METHODS: Immunohistochemical techniques were used to study the expression of serotonin in the lesions of patients with chronic eczema.
RESULTS: There was a significantly stronger expression of serotonin in the prickle cells, sweat gland cells, sebaceous gland cells, and hair roots of the lesions in patients with chronic eczema. There was no positive expression of serotonin in normal skin.
CONCLUSIONS: Serotonin is probably important in the pathogenesis of chronic eczema. We demonstrated alterations in the expression of serotonin in chronic eczema lesions, which may in turn provide new insight into the pathogenesis of chronic eczema. Serotonin, along with cytokines, T lymphocytes, B lymphocytes, and macrophages, participates in the immune response and influences the inflammatory process by means of keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485527     DOI: 10.1111/j.1365-4632.2004.02196.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  14 in total

1.  Neuroendocrine regulators: Novel trends in sebaceous gland research with future perspectives for the treatment of acne and related disorders.

Authors:  Markus Böhm
Journal:  Dermatoendocrinol       Date:  2009-05

2.  Immunohistochemical Evaluation of Role of Serotonin in Pathogenesis of Psoriasis.

Authors:  Sheren Fouad Younes; Ola Ahmed Bakry
Journal:  J Clin Diagn Res       Date:  2016-10-01

3.  HTR7 Mediates Serotonergic Acute and Chronic Itch.

Authors:  Takeshi Morita; Shannan P McClain; Lyn M Batia; Maurizio Pellegrino; Sarah R Wilson; Michael A Kienzler; Kyle Lyman; Anne Sofie Braun Olsen; Justin F Wong; Cheryl L Stucky; Rachel B Brem; Diana M Bautista
Journal:  Neuron       Date:  2015-06-11       Impact factor: 17.173

4.  Enhanced scratching evoked by PAR-2 agonist and 5-HT but not histamine in a mouse model of chronic dry skin itch.

Authors:  T Akiyama; M Iodi Carstens; E Carstens
Journal:  Pain       Date:  2010-08-14       Impact factor: 6.961

5.  Innocuous warming enhances peripheral serotonergic itch signaling and evokes enhanced responses in serotonin-responsive dorsal horn neurons in the mouse.

Authors:  T Akiyama; M Nagamine; A Davoodi; M Ivanov; M Iodi Carstens; E Carstens
Journal:  J Neurophysiol       Date:  2016-10-26       Impact factor: 2.714

6.  Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor.

Authors:  Matilde León-Ponte; Gerard P Ahern; Peta J O'Connell
Journal:  Blood       Date:  2006-12-07       Impact factor: 22.113

Review 7.  The Return of the Mast Cell: New Roles in Neuroimmune Itch Biology.

Authors:  Fang Wang; Ting-Lin B Yang; Brian S Kim
Journal:  J Invest Dermatol       Date:  2020-04-02       Impact factor: 8.551

8.  Molecular signaling and targets from itch: lessons for cough.

Authors:  Pamela Colleen Lavinka; Xingzhong Dong
Journal:  Cough       Date:  2013-03-06

9.  Involvement of TRPV4 in Serotonin-Evoked Scratching.

Authors:  Tasuku Akiyama; Margaret Ivanov; Masaki Nagamine; Auva Davoodi; Mirela I Carstens; Akihiko Ikoma; Ferda Cevikbas; Cordula Kempkes; Joerg Buddenkotte; Martin Steinhoff; E Carstens
Journal:  J Invest Dermatol       Date:  2016-01       Impact factor: 8.551

10.  A human and animal model-based approach to investigating the anti-inflammatory profile and potential of the 5-HT2B receptor antagonist AM1030.

Authors:  Niklas Palmqvist; Max Siller; Cecilia Klint; Anders Sjödin
Journal:  J Inflamm (Lond)       Date:  2016-06-22       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.